CU24142B1 - Composiciones nasales de vitamina b12 - Google Patents
Composiciones nasales de vitamina b12Info
- Publication number
- CU24142B1 CU24142B1 CU20130062A CU20130062A CU24142B1 CU 24142 B1 CU24142 B1 CU 24142B1 CU 20130062 A CU20130062 A CU 20130062A CU 20130062 A CU20130062 A CU 20130062A CU 24142 B1 CU24142 B1 CU 24142B1
- Authority
- CU
- Cuba
- Prior art keywords
- vitamin
- nasal compositions
- nasal
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2169MU2010 | 2010-10-29 | ||
| PCT/IB2011/002546 WO2012056299A1 (en) | 2010-10-29 | 2011-10-28 | Nasal compositions of vitamin b12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CU20130062A7 CU20130062A7 (es) | 2013-10-29 |
| CU24142B1 true CU24142B1 (es) | 2015-12-23 |
Family
ID=45350421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20130062A CU24142B1 (es) | 2010-10-29 | 2011-10-28 | Composiciones nasales de vitamina b12 |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP2632430B1 (es) |
| JP (1) | JP5843873B2 (es) |
| CN (1) | CN103384513B (es) |
| AP (1) | AP3814A (es) |
| AR (1) | AR083658A1 (es) |
| BR (1) | BR112013010049B1 (es) |
| CO (1) | CO6801717A2 (es) |
| CU (1) | CU24142B1 (es) |
| DK (1) | DK2632430T3 (es) |
| EA (1) | EA024475B1 (es) |
| ES (1) | ES2686299T3 (es) |
| HU (1) | HUE039349T2 (es) |
| MX (1) | MX337365B (es) |
| MY (1) | MY163106A (es) |
| PE (1) | PE20131137A1 (es) |
| PL (1) | PL2632430T3 (es) |
| PT (1) | PT2632430T (es) |
| UA (1) | UA111342C2 (es) |
| WO (1) | WO2012056299A1 (es) |
| ZA (1) | ZA201303024B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2767062C2 (ru) * | 2016-06-24 | 2022-03-16 | Опиант Фармасьютикалз, Инк. | Составы, устройства и способы для лечения алкогольной зависимости |
| AU2017360910B2 (en) | 2016-11-18 | 2023-11-23 | Aegis Therapeutics, Llc | Compositions and methods for the treatment of opioid overdose |
| WO2018142358A1 (en) * | 2017-02-06 | 2018-08-09 | Torrent Pharmaceuticals Ltd. | Intranasal composition of methylcobalamin |
| EP3634413A1 (en) * | 2017-06-09 | 2020-04-15 | Exelixis, Inc. | Liquid dosage forms to treat cancer |
| GB202013645D0 (en) | 2020-08-31 | 2020-10-14 | Innotesto Bvba | Pharmacetical compositions for the nasal administration of a colbalamin compound |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT376879B (de) * | 1982-10-27 | 1985-01-10 | Gerot Pharmazeutika | Verfahren zur herstellung einer injektionsloesung |
| US4724231A (en) * | 1985-04-16 | 1988-02-09 | Nastech Pharmaceutical, Inc. | Nasel compositions containing vitamin B12 |
| ES2074396B1 (es) * | 1993-03-24 | 1996-04-01 | Farmalider Sa | Sistema de administracion nasal de cianocobalamina (vitamina b12). |
| BE1007839A6 (nl) * | 1993-12-20 | 1995-10-31 | Merkus Franciscus W H M Prof | Farmaceutische compositie voor de nasale toediening van hydroxocobalamine. |
| US7229636B1 (en) * | 2003-03-04 | 2007-06-12 | Nastech Pharmaceutical Company Inc. | Cyanocobalamin low viscosity aqueous formulations for intranasal delivery |
| ES2356242T3 (es) * | 2003-05-07 | 2011-04-06 | EISAI R&D MANAGEMENT CO., LTD. | Preparación liofilizada conteniendo metilcobalamina y procedimiento de producción de esta preparación. |
| WO2007022345A2 (en) * | 2005-08-17 | 2007-02-22 | Fleming And Company, Pharmaceuticals | Vitamin b12 nasal spray and method of use |
| KR20140101010A (ko) * | 2006-06-23 | 2014-08-18 | 파 파마슈티컬, 인크. | 비내 전달용 시아노코발라민 저점도 수성 제형 |
| US20090012039A1 (en) * | 2007-03-16 | 2009-01-08 | Stan Kurtz | Use of methylcobalamin nasal spray to treat disorders |
| DE102007012644A1 (de) * | 2007-03-16 | 2008-09-18 | Bayer Healthcare Ag | Stabilisierung von Vitamin B12 |
-
2011
- 2011-10-28 AP AP2013006837A patent/AP3814A/en active
- 2011-10-28 WO PCT/IB2011/002546 patent/WO2012056299A1/en active Application Filing
- 2011-10-28 ES ES11797111.9T patent/ES2686299T3/es active Active
- 2011-10-28 MY MYPI2013000794A patent/MY163106A/en unknown
- 2011-10-28 EA EA201390623A patent/EA024475B1/ru unknown
- 2011-10-28 HU HUE11797111A patent/HUE039349T2/hu unknown
- 2011-10-28 PT PT11797111T patent/PT2632430T/pt unknown
- 2011-10-28 DK DK11797111.9T patent/DK2632430T3/en active
- 2011-10-28 PL PL11797111T patent/PL2632430T3/pl unknown
- 2011-10-28 PE PE2013000547A patent/PE20131137A1/es active IP Right Grant
- 2011-10-28 EP EP11797111.9A patent/EP2632430B1/en active Active
- 2011-10-28 MX MX2013004846A patent/MX337365B/es active IP Right Grant
- 2011-10-28 JP JP2013535525A patent/JP5843873B2/ja active Active
- 2011-10-28 UA UAA201306483A patent/UA111342C2/uk unknown
- 2011-10-28 BR BR112013010049-4A patent/BR112013010049B1/pt active IP Right Grant
- 2011-10-28 CN CN201180057382.6A patent/CN103384513B/zh active Active
- 2011-10-28 CU CU20130062A patent/CU24142B1/es unknown
- 2011-10-31 AR ARP110104028A patent/AR083658A1/es not_active Application Discontinuation
-
2013
- 2013-04-25 ZA ZA2013/03024A patent/ZA201303024B/en unknown
- 2013-05-24 CO CO13128213A patent/CO6801717A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AP3814A (en) | 2016-09-30 |
| CN103384513A (zh) | 2013-11-06 |
| CU20130062A7 (es) | 2013-10-29 |
| DK2632430T3 (en) | 2018-09-17 |
| WO2012056299A1 (en) | 2012-05-03 |
| MY163106A (en) | 2017-08-15 |
| CO6801717A2 (es) | 2013-11-29 |
| MX337365B (es) | 2016-02-29 |
| ES2686299T3 (es) | 2018-10-17 |
| PL2632430T3 (pl) | 2018-11-30 |
| PT2632430T (pt) | 2018-10-19 |
| BR112013010049A2 (pt) | 2018-01-09 |
| HUE039349T2 (hu) | 2018-12-28 |
| AP2013006837A0 (en) | 2013-04-30 |
| EP2632430B1 (en) | 2018-06-06 |
| UA111342C2 (uk) | 2016-04-25 |
| JP2013540805A (ja) | 2013-11-07 |
| EA024475B1 (ru) | 2016-09-30 |
| AR083658A1 (es) | 2013-03-13 |
| MX2013004846A (es) | 2013-10-01 |
| ZA201303024B (en) | 2014-01-29 |
| EP2632430A1 (en) | 2013-09-04 |
| JP5843873B2 (ja) | 2016-01-13 |
| PE20131137A1 (es) | 2013-10-03 |
| BR112013010049B1 (pt) | 2021-07-13 |
| EA201390623A1 (ru) | 2013-09-30 |
| CN103384513B (zh) | 2016-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201700008B (it) | Composizione farmaceutica | |
| SMT201600350B (it) | Composizioni farmaceutiche | |
| BR112014003052A2 (pt) | composições farmacêuticas | |
| CO6852076A2 (es) | Composiciones farmacéuticas inhalables | |
| DK2939692T3 (da) | Nasal influenzavaccinesammensætning | |
| BR112013017183A2 (pt) | composições de bepostatina | |
| DK2694038T3 (da) | Farmaceutisk sammensætning | |
| DK3246018T3 (da) | Farmaceutisk sammensætning | |
| CO6930367A2 (es) | Composiciones farmaceúticas | |
| CO6930368A2 (es) | Composiciones de yodo-povidona estable | |
| AR092198A1 (es) | Derivados de pirazolopirimidinas | |
| BR112013025845A2 (pt) | formulações com viscosidade reduzida | |
| BR112014003878A2 (pt) | síntese de r-bifenilalaninol | |
| EE201300005A (et) | Ravimkoostis | |
| BR112014009963A2 (pt) | composição dietética | |
| CO6801717A2 (es) | Composiciones nasales de vitamina b12 | |
| PL2766008T3 (pl) | Kompozycja do podawania donosowego o ulepszonej stabilności | |
| FR2987600B1 (fr) | Nacelle aplatie de turboreacteur | |
| BR112012029461A2 (pt) | composição farmacêutica contendo solifenacina | |
| ZA201402165B (en) | Compositions of lopinavir | |
| IL224192A (en) | Compositions of Vitamin 14 – Epi Analogs d | |
| CO7010827A2 (es) | Composiciones mejoradas | |
| BR112013022907A2 (pt) | composição farmacêutica | |
| BR112013014710A2 (pt) | entrega de compostos funcionais | |
| FR2955136B1 (fr) | Arret de vantail |